GlassScriptPhysician profile
Jason Michael Greenfield
NPI 1659385268
$19,322.23
in general payments reported to CMS, 2019-2025
42 companies · $508 in 2025
The $508 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $853 · 2021: $602 · 2022: $443 · 2023: $940 · 2024: $926 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,759 · Travel and Lodging: $480 · Education: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,758.76 |
| Travel and Lodging | $479.62 |
| Education | $136.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $10,164.35 | 2019-2021 | |
| Boston Scientific Corporation | $2,248.53 | 2019-2025 | General - Erectile Dysfunction, General - Kidney Stone Disease, Ams 700 |
| Coloplast Corp | $1,635.47 | 2019-2024 | |
| Gyrus Acmi, INC. | $1,547.50 | 2019 | |
| Teleflex LLC | $960.16 | 2022-2024 | Urolift |
| Astellas Pharma US INC | $447.06 | 2019-2023 | Xtandi |
| Procept Biorobotics Corporation | $297.26 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Bayer Healthcare Pharmaceuticals INC. | $154.84 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $147.91 | 2019-2023 | Provenge |
| Sumitomo Pharma America, INC. | $143.58 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $136.00 | 2024-2025 | Erleada |
| Neotract INC. | $128.70 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $118.15 | 2019 | |
| 180 Medical, INC. | $111.47 | 2019-2025 | Gentlecath Glide |
| Amgen INC. | $109.14 | 2019-2023 | Xgeva |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Greenfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.